Skip to content

भाषा बदलें: हिंदी में

mTatva Health-PIE

  • Home
  • Health Articles
  • Disease Facts
  • Drug Facts – Brands
  • Drug Facts – Generics

Category: MULTIKINASE INHIBITORS

Drug Classification

VEMURAFENIB

September 13, 2018 mTatva Health

VEMURAFENIB is a Schedule H drug.

MULTIKINASE INHIBITORSmedicine for body discoloration, medicine for erdheim chester syndrome, medicine for melanoma

VANDETANIB

September 13, 2018 mTatva Health

VANDETANIB is a Schedule H drug.

EGFR INHIBITORS, MULTIKINASE INHIBITORS, VEGF/VEGFR INHIBITORSmedicine for cough, medicine for difficulty breathing, medicine for difficulty swallowing, medicine for hoarse voice, medicine for neck lump or bulge, medicine for neck pain, medicine for thyroid cancer

TRAMETINIB

September 13, 2018 mTatva Health

TRAMETINIB is a Schedule H drug.

MULTIKINASE INHIBITORSmedicine for body discoloration, medicine for cough, medicine for difficulty breathing, medicine for difficulty swallowing, medicine for loss of voice, medicine for lung cancer, medicine for melanoma, medicine for neck lump or bulge, medicine for neck pain, medicine for throat tightness, medicine for thyroid cancer

SUNITINIB

September 13, 2018 mTatva Health

SUNITINIB is a Schedule H drug.

MULTIKINASE INHIBITORS, VEGF/VEGFR INHIBITORSmedicine for kidney cancer, medicine for small intestine cancer, medicine for stomach cancer

SORAFENIB

September 13, 2018 mTatva Health

SORAFENIB is a Schedule H drug.

MULTIKINASE INHIBITORS, VEGF/VEGFR INHIBITORSmedicine for kidney cancer, medicine for liver cancer, medicine for renal cell carcinoma, medicine for thyroid cancer

RUXOLITINIB

September 13, 2018 mTatva Health

RUXOLITINIB is a Schedule H drug.

MULTIKINASE INHIBITORSmedicine for myelofibrosis, medicine for polycythemia vera

PONATINIB

September 13, 2018 mTatva Health

PONATINIB is a Schedule H drug.

BCR-ABL TYROSINE KINASE INHIBITORS, MULTIKINASE INHIBITORS, VEGF/VEGFR INHIBITORSmedicine for acute lymphoblastic leukemia, medicine for leukemia myeloid

COBIMETINIB

September 13, 2018 mTatva Health

COBIMETINIB is a Schedule H drug.

MULTIKINASE INHIBITORSmedicine for melanoma, medicine for skin cancer

CABOZANTINIB

September 13, 2018 mTatva Health

CABOZANTINIB is a Schedule H drug.

MULTIKINASE INHIBITORS, VEGF/VEGFR INHIBITORSmedicine for kidney cancer, medicine for renal cell carcinoma, medicine for thyroid cancer

AXITINIB

September 13, 2018 mTatva Health

AXITINIB is an Over-the-counter (OTC) drug.

MULTIKINASE INHIBITORS, VEGF/VEGFR INHIBITORSmedicine for kidney cancer, medicine for renal cell carcinoma

Posts navigation

1 2 Next

Like us

Top Posts & Pages

  • JUNIOR LANZOL SYP
  • Conjunctivitis: Treatment, Diet and Home Remedies
  • Stye: Treatment, Diet and Home Remedies
  • Tuberculosis: Treatment, Diet and Home Remedies
  • Appendicitis: Treatment, Diet and Home Remedies
  • Meningitis: Treatment, Diet and Home Remedies
  • Laryngitis: Treatment, Diet and Home Remedies
  • Folliculitis: Treatment, Diet and Home Remedies
  • Mumps: Treatment, Diet and Home Remedies
  • Hematoma: Treatment, Diet and Home Remedies

Recent Posts

  • Games changers of Healthcare – AI and IoMT
  • ULTRAMED 325MG/37.5MG TAB
  • ULTRAM 325MG/37.5MG TAB
  • ULTRAGIN 500MG TAB
  • ULTRACET SEMI 162.5MG/18.75MG TAB
  • ULTRACET 325MG/37.5MG TAB
  • ULTRABEST 37.5MG/325MG TAB
  • ULTRA PLUS H 162.5MG/18.75MG TAB
  • ULTRA PLUS 325MG/37.5MG TAB
  • ULTIMIDE 750MG TAB
  • ULTIFIX PLUS TAB
  • ULTIFIX LB TAB
  • ULTIFIX CV 250MG/125MG TAB
  • ULTIFIX 50MG TAB DT
  • ULTIFIX 50MG DRY SYP
  • ULTIFIX 200MG TAB DT
  • ULTIFIX 100MG TAB DT
  • ULTICAN 150MG TAB
  • ULEEV 250MG TAB
  • UCO 150MG TAB
  • 1 2 3 100MG TAB
  • 1 2 3 25MG TAB
  • 1 2 3 50MG TAB
  • 1 AL 10MG TAB
  • 1 AL 2.5MG SYP
  • Home
  • Health Articles
  • Disease Facts
  • Drug Facts – Brands
  • Drug Facts – Generics
Copyright Since 2013. All rights reserved @mTatva
Proudly powered by WordPress | Education Hub by WEN Themes
X
Your Personal Doctor on Mobile
Get 1000+ diseases comprehensive information on your mobile
Download App Now